Nadkarni, Abhijay N.
(2023)
Associations of Brain Injury Biomarkers in Serum with Gait Measures: The Cardiovascular Health Study.
Master Essay, University of Pittsburgh.
This is the latest version of this item.
Abstract
Gait impairment leads to adverse health consequences and has neurological contributions. However, little is known of how specific brain injury biomarkers are associated with multiple quantitative gait measures. Therefore, this study explored how plasma biomarkers of brain injury are related to gait measures in older adults. We hypothesized that higher levels of neurofilament light-chain (NfL) and glial fibrillary acidic protein (GFAP), but lower levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and total tau, predict worse gait performance. Participants (n=1959, mean age=78.0 years) were selected from a population-based cohort study and followed from 1998 to 2000. They received a serum biomarker assessment (Quanterix™) at year 9 for NfL, GFAP, UCH-L1, and total tau. Gait speed was measured each year over a 15-ft walkway. Linear mixed effects models assessed the longitudinal association of serum biomarkers with gait speed at year 9 and the annual change, adjusting for demographic factors. A subsample (n=380, mean age=77.6 years) was assessed on a gait mat at year 9 for gait speed, step length, double support time, step time, step length variability and step time variability. Spearman’s correlations and linear regression adjusted for demographic factors assessed the cross-sectional relationship between serum biomarkers and gait mat measures. NfL was significantly associated with baseline gait speed (standardized β= -0.93 m/s [95% CI: -1.62, -0.24]) and the annual change in gait speed (standardized β = -0.69 m/s [-1.28, -0.10]) after adjustment. Results were similar in the gait mat subsample where NfL was significantly associated with gait speed cross-sectionally. No other biomarkers were significantly related to gait measures in longitudinal or cross-sectional analyses. Higher NfL levels were related to slower baseline gait speed and a greater annual decline over 2 years. Gait speed decline may be related to specific aspects of axonal degeneration. Our study can further inform public health efforts to screen those vulnerable to gait impairment.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Other Thesis, Dissertation, or Long Paper
(Master Essay)
|
Status: |
Unpublished |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID ![](/images/orcid_id_24x24.png) |
---|
Nadkarni, Abhijay N. | ann71@pitt.edu | ann71 | |
|
Contributors: |
Contribution | Contributors Name | Email | Pitt Username | ORCID ![](/images/orcid_id_24x24.png) |
---|
Committee Chair | Rosso, Andrea | alr143@pitt.edu | alr143 | UNSPECIFIED | Committee Member | Brach, Jennifer | jbrach@pitt.edu | jbrach | UNSPECIFIED | Committee Member | Mukamal, Kenneth | kmukamal@bidmc.harvard.edu | UNSPECIFIED | UNSPECIFIED |
|
Date: |
5 January 2023 |
Date Type: |
Completion |
Number of Pages: |
43 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Public Health > Epidemiology |
Degree: |
MPH - Master of Public Health |
Thesis Type: |
Master Essay |
Refereed: |
No |
Uncontrolled Keywords: |
serum, biomarkers, brain injury, gait, CHS, Cardiovascular Health Study, NfL tau, UCH-L1, GFAP |
Date Deposited: |
05 Jan 2023 14:30 |
Last Modified: |
05 Jan 2023 14:30 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/44024 |
Available Versions of this Item
-
Associations of Brain Injury Biomarkers in Serum with Gait Measures: The Cardiovascular Health Study. (deposited 05 Jan 2023 14:30)
[Currently Displayed]
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
![View Item View Item](/style/images/action_view.png) |
View Item |